RVPH icon

Reviva Pharmaceuticals
RVPH

Overview Fund Activity

24 hedge funds and large institutions have $13M invested in Reviva Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
8
Closed
4
Calls
$9.37M
Puts
$10.1M
Net Calls
-$723K
Net Calls Change
-$10.8M

Top Buyers

1
Group One Trading
Group One Trading
Illinois
$631K
2
ECM
EMC Capital Management
Texas
$613K
3
GCP
GSA Capital Partners
United Kingdom
$342K
4
SM
Sabby Management
Florida
$218K
5
Belvedere Trading
Belvedere Trading
Illinois
$242K

Top Sellers

1
AC
Armistice Capital
New York
$2.93M
2
Citadel Advisors
Citadel Advisors
Florida
$47K
3
Renaissance Technologies
Renaissance Technologies
New York
$0
4
Millennium Management
Millennium Management
New York
$2.06M
5
VF
Virtu Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
26
Virtu Financial
New York
– -$108K -18,448 Closed
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
– -$78K -13,382 Closed
TRCT
28
Tower Research Capital (TRC)
New York
– -$65.1K -11,109 Closed
1
2